Skip to main content
. 2022 Feb 15;43(12):1873–1879. doi: 10.1017/ice.2021.529

Table 2.

Crude and Adjusted Odds Ratios for Postoperative Outcomes Based on Type of Antimicrobial Prophylaxis

Postoperative outcomesa,b Crude Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Clindamycin Vancomycin Multiple Clindamycin Vancomycin Multiple
30-day SSI 2.0 (0.9–4.7) 2.0 (1.1–3.9) 1.8 (0.4–7.3) 2.1 (0.9–4.9) 1.8 (0.9–3.5) 2.3 (0.5–10.0)
7-day AKI c 0.4 (0.1–1.7) 0.9 (0.3–2.2) 0.8 (0.1–6.4) 0.4 (0.8–1.6) 0.5 (0.2–1.4) 0.8 (0.9–6.2)
90-day CDI c 1.5 (0.2–11.5) 0.8 (0.1–6.3) 8.2 (1.8–36.4) 1.5 (0.2–12.1) 0.6 (0.8–5.2) 5.5 (1.1–28.2)
Prolonged hospital LOS c 1.0 (0.7–1.3) 1.2 (1.0–1.5) 3.1 (2.0–4.7) 1.1 (0.8–1.4) 1.0 (0.8–1.3) 1.4 (0.9–2.3)
30-day reoperation 0.6 (0.2–1.4) 1.4 (0.9–2.1) 4.9 (2.7–8.7) 0.6 (0.3–1.6) 1.2 (0.7–1.9) 2.3 (1.2–4.4)

Note. CI, confidence interval; SSI, surgical site infection; AKI, acute kidney injury; CDI, Clostridioides difficile infection; LOS, length of stay; UTI, urinary tract infection; P < 0.5 for values in bold.

a

Reference group is cefazolin.

b

All multivariate models adjusted for age, BMI, diabetes mellitus, hypertension, ASA classification, tobacco use, corticosteroid use, surgery type, duration of surgery, and duration of prophylactic antimicrobials (1, 2, 3, and ≥4 days).

c

The multivariate models for 7-day AKI, 90-day CDI, and prolonged hospital LOS are also adjusted for other postoperative infections (sepsis, pneumonia, UTI).